New York City mayoral candidate Andrew Cuomo plans to make New York a cryptocurrency hub
According to Jinse Finance, crypto journalist Eleanor Terrett has revealed that New York City mayoral candidate Andrew Cuomo (@andrewcuomo) plans to turn New York into a cryptocurrency hub. The former New York State governor, now a mayoral candidate, intends to announce that if elected, he will establish the position of "Chief Innovation Officer" (CIO), dedicated to making New York City the "global center of the future." The Chief Innovation Officer will coordinate initiatives across New York City government agencies in the fields of blockchain, artificial intelligence (AI), and biotechnology, aiming to attract jobs and investment, and to advance the city's modernization in the application and integration of new technologies. Reportedly, Cuomo's plan also includes forming an "Innovation Council," which will consist of three advisory groups responsible for the fields of cryptocurrency, AI, and biotechnology. This council will provide expert advice on the promotion of technology applications in these emerging industries, workforce development, and streamlining administrative processes (reducing red tape).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Crypto prices
More
